poliovirus
mutat
polymeras
enhanc
replic
fidel
attenu
anim
model
describ
mous
virul
properti
high
replic
fidel
polymeras
variant
human
enteroviru
mutat
posit
plu
mouseadapt
strain
construct
order
compar
virul
polymeras
variant
mouseadapt
parent
viru
attenu
mice
mean
surviv
time
day
pi
respect
compar
mean
surviv
time
day
pi
respect
infect
induc
earli
onset
sever
generalis
necrotis
myositi
wherea
infect
induc
later
onset
mild
focal
skelet
muscl
myositi
find
demonstr
mutat
attenu
mice
suggest
high
replic
fidel
phenotyp
essenti
virul
attenu
model
human
enteroviru
belong
genu
enteroviru
within
famili
picornavirida
knowl
et
al
first
discov
recent
emerg
import
caus
handfootandmous
diseas
hfmd
associ
high
frequenc
acut
neurolog
diseas
mcminn
polioviru
polymeras
pol
recent
gain
attent
promis
virul
attenu
target
pfeiffer
kirkegaard
vignuzzi
et
al
polioviru
variant
mutat
pol
code
region
shown
express
high
replic
fidel
attenu
polioviru
receptorexpress
transgen
mice
pfeiffer
kirkegaard
vignuzzi
et
al
vignuzzi
et
al
furthermor
mutat
polioviru
pol
shown
greatli
reduc
viral
fit
attenu
virul
vignuzzi
et
al
attenu
mutat
increas
replic
fidel
polioviru
pol
also
shown
prevent
revers
virul
parent
viru
phenotyp
pfeiffer
kirkegaard
vignuzzi
et
al
furthermor
recent
identifi
two
mutat
pol
posit
increas
correspond
author
tel
fax
email
address
petermcminn
sydneyeduau
pc
mcminn
replic
fidel
growth
cell
cultur
sadeghipour
et
al
studi
examin
relationship
pol
mutat
confer
high
replic
fidel
phenotyp
upon
virul
phenotyp
mice
investig
virul
strain
contain
pol
mutat
posit
plu
doubl
mutant
newborn
balbc
mous
model
infect
chua
et
al
human
endpoint
mean
length
surviv
viral
distribut
mous
tissu
histolog
studi
undertaken
order
compar
virul
pol
variant
virul
parent
viru
strain
subgenotyp
isol
western
australia
chua
et
al
mcminn
et
al
outbreak
hand
foot
mouth
diseas
fulli
sequenc
use
gener
infecti
cdna
clone
chua
et
al
mouseadapt
strain
chua
et
al
human
rhabdomyosarcoma
rd
atcc
number
african
green
monkey
kidney
vero
atcc
number
simian
viru
african
green
monkey
kidney
cell
line
maintain
c
co
mainten
medium
dulbecco
modifi
eagl
medium
dmem
hyclon
supplement
foetal
bovin
serum
fb
bovogen
biolog
mm
lglutamin
sigma
growth
medium
dmem
supplement
fb
mm
lglutamin
order
select
strain
high
replic
fidel
sadeghipour
et
al
sadeghipour
et
al
mutat
introduc
sitedirect
mutagenesi
use
lightn
quickchang
mutagenesi
kit
stratagen
code
region
fragment
carri
mutat
clone
infecti
cdna
clone
digest
mlui
ecorv
produc
sadeghipour
et
al
sadeghipour
et
al
respect
gene
fragment
carri
mutat
also
clone
mouseadapt
infecti
cdna
clone
digest
mlui
ecorv
gener
respect
recombin
fulllength
plasmid
transfect
cell
use
lipofectamin
invitrogen
rescu
clonederiv
viru
cdv
briefli
g
either
g
express
rna
polymeras
dilut
final
volum
l
contain
l
lipofectamin
l
optimem
invitrogen
two
solut
incub
min
combin
incub
min
room
temperatur
cell
tissu
cultur
plate
cellstar
cover
l
optimem
solut
h
incub
c
l
growth
medium
ad
transfect
cell
incub
h
transfect
cell
subject
three
cycl
freezethaw
supernat
clarifi
centrifug
g
min
l
transfect
cell
lysat
use
infect
rd
cell
sixwel
plate
cdv
passag
rd
cell
obtain
work
stock
cdvinfect
cell
cultur
supernat
subject
viral
rna
extract
use
qiaamp
viral
rna
minikit
qiagen
viral
cdna
synthesi
perform
use
superscript
iii
invitrogen
utrr
primer
viral
cdna
amplifi
polymeras
chain
reaction
pcr
follow
nucleotid
sequenc
code
region
confirm
presenc
mutat
code
region
confirm
presenc
mous
adapt
marker
characteris
doubl
mutant
investig
ribavirin
resist
phenotyp
growth
compar
parent
rd
cell
cultur
h
presenc
ribavirin
briefli
rd
cell
plate
cellstar
cover
dmem
contain
ribavirin
h
c
ribavirinpretr
rd
cell
wash
phosphatebuff
salin
ph
pb
cell
infect
moi
parent
h
c
wash
pb
follow
addit
mainten
medium
contain
either
ribavirin
infect
cell
cultur
incub
c
co
h
conclus
experi
viru
releas
cell
freezethaw
lysat
clarifi
centrifug
g
min
titr
lysat
determin
tcid
assay
vero
cell
follow
reed
muench
reed
muench
twelvewel
tissu
cultur
tray
cellstar
seed
vero
cell
densiti
cellswel
grown
overnight
c
tenfold
serial
dilut
viru
inocul
onto
vero
cell
monolay
volum
l
per
well
incub
min
c
viru
remov
cell
wash
pb
cell
overlaid
ml
mainten
medium
contain
immunodiffusiongrad
agaros
icn
incub
c
co
four
day
incub
addit
ml
mainten
medium
contain
immunodiffusiongrad
agaros
ad
well
cultur
incub
three
day
isol
plaqu
select
use
pipett
tip
draw
cell
within
plaqu
protocol
repeat
three
time
order
select
plaquepurifi
viru
popul
characteris
guanidin
sensit
plaquepurifi
popul
passag
rd
cell
presenc
ribavirin
guanidin
sensit
plaquepurifi
popul
compar
plaquepurifi
popul
parent
growth
presenc
either
mm
mm
guanidin
h
briefli
rd
cell
infect
moi
sixwel
plate
cellstar
h
c
cell
wash
pb
mainten
medium
contain
either
mm
mm
guanidin
ad
cell
incub
c
co
h
viru
releas
cell
freezethaw
lysat
clarifi
centrifug
g
min
titr
lysat
determin
tcid
assay
describ
reed
muench
viral
rna
extract
parent
one
thirteen
passag
rd
cell
presenc
ribavirin
use
qiaamp
viral
rna
mini
kit
qiagen
l
viral
rna
revers
transcrib
use
superscript
iii
invitrogen
utrr
primer
viral
cdna
amplifi
pcr
gelpurifi
use
minelut
gel
extract
kit
qiagen
nucleotid
sequenc
code
region
perform
australian
genom
research
facil
analysi
dna
chromatogram
perform
use
program
chroma
tm
version
technelysium
pti
ltd
australia
sequench
version
gen
code
corpor
statist
analys
perform
use
twotail
student
ttest
p
valu
consid
statist
signific
rd
cell
monolay
cell
per
well
grown
overnight
tissu
cultur
plate
cellstar
infect
moi
h
c
cell
wash
pb
overlaid
l
mainten
medium
per
well
viru
collect
four
hourli
interv
h
freezethaw
clarifi
centrifug
g
min
first
time
point
h
collect
immedi
addit
mainten
medium
yield
quantifi
tcid
assay
describ
reed
muench
order
minimis
distress
experiment
anim
human
endpoint
hd
use
instead
lethal
endpoint
ld
human
endpoint
assay
shown
statist
ident
lethal
endpoint
virul
assay
wright
phillpott
group
six
balbc
mice
infect
intraperiton
ip
inocul
l
tenfold
serial
dilut
mockinfect
mice
inocul
diluent
dmem
monitor
clinic
sign
infect
day
mice
develop
grade
paralysi
hunch
postur
flaccid
paralysi
euthanis
hd
valu
balbc
mice
calcul
use
method
reed
muench
reed
muench
group
six
balbc
mice
infect
ip
l
dmem
contain
tcid
mockinfect
mice
inocul
diluent
dmem
mice
monitor
twice
daili
day
pi
percentag
surviv
calcul
group
mice
show
grade
paralysi
greater
euthanis
statist
analys
perform
use
mantelcox
logrank
test
p
valu
consid
statist
signific
group
fivedayold
balbc
mice
infect
ip
hd
indic
time
pi
three
mice
group
euthanis
ip
inject
mixtur
xylazin
mg
ml
ketamin
mg
ml
pb
dose
lg
bodi
weight
whole
blood
collect
intracardiac
punctur
store
c
perfus
pb
tissu
sampl
collect
weigh
individu
snapfrozen
liquid
nitrogen
store
c
tissu
homogenis
dounc
homogenis
homogen
prepar
wv
suspens
hank
balanc
salt
solut
ph
hbss
viru
titr
tissu
homogen
determin
tcid
assay
vero
cell
viral
titr
blood
determin
tcid
ml
viral
titr
tissu
homogen
determin
tcid
g
skelet
muscl
tissu
histolog
analysi
collect
three
infect
mice
demonstr
clinic
sign
infect
grade
greater
fix
buffer
formalin
overnight
dehydr
ethanol
embed
paraffin
tissu
specimen
sever
section
cut
microtom
mount
onto
glass
slide
vwr
labwar
stain
haematoxylin
eosin
statist
analys
perform
use
oneway
anova
tukey
multipl
comparison
test
mantelcox
logrank
test
twotail
student
ttest
p
valu
consid
statist
signific
data
analys
use
graphpad
prism
onlin
softwar
packag
previous
shown
mutat
confer
ribavirin
resist
upon
increas
replic
fidel
pol
sadeghipour
et
al
furthermor
shown
amino
acid
substitut
posit
polioviru
pol
induc
resist
ribavirin
increas
replic
fidel
also
lead
reduc
virul
polioviru
receptorexpress
transgen
mice
kirkegaard
vignuzzi
et
al
vignuzzi
et
al
thu
interest
determin
pol
mutat
also
abl
attenu
viral
virul
mous
model
infect
chua
et
al
order
select
strain
high
replic
fidel
stabl
attenu
virul
doubl
mutant
strain
incorpor
construct
sitedirect
mutagenesi
infecti
cdna
clone
chua
et
al
gener
variant
cdv
passag
ten
time
rd
cell
assess
stabil
introduc
mutat
passag
cell
cultur
mutat
remain
stabli
present
ten
passag
doubl
mutant
cdv
rd
cell
data
shown
first
step
characteris
phenotyp
determin
ribavirin
resist
rna
copi
fidel
phenotyp
previous
shown
mutat
respons
ribavirinresist
phenotyp
sadeghipour
et
al
order
examin
suscept
doubl
mutant
cdv
popul
ribavirin
parent
grown
rd
cell
h
presenc
absenc
ribavirin
respect
result
experi
shown
fig
ratio
rd
cell
growth
titr
parent
variant
cdv
popul
presenc
absenc
ribavirin
shown
fig
expect
capabl
growth
presenc
ribavirin
tcid
ml
lower
titr
absenc
ribavirin
tcid
ml
contrast
growth
parent
strongli
inhibit
presenc
ribavirin
tcid
ml
titr
approxim
growth
titr
absenc
ribavirin
tcid
ml
expect
experi
confirm
resist
growth
presenc
ribavirin
previous
observ
cdv
incorpor
singl
pol
mutat
sadeghipour
et
al
previous
shown
mutat
impact
significantli
growth
cdv
popul
rd
cell
sadeghipour
et
al
singlestep
growth
kinet
studi
perform
order
determin
higher
titr
growth
polymeras
variant
rd
cell
presenc
ribavirin
compar
parent
viru
due
either
wholli
partli
increas
replic
capac
rd
cell
infect
moi
viru
growth
measur
h
time
cours
growth
kinet
rd
cell
compar
parent
viru
fig
absenc
ribavirin
pressur
parent
viru
popul
grew
effici
rd
cell
statist
signific
differ
p
observ
singlestep
growth
kinet
fig
thu
mutat
impact
significantli
growth
cdv
popul
rd
cell
virus
harvest
four
hourli
interv
h
yield
quantifi
assay
vero
cell
reed
muench
experi
perform
triplic
error
bar
indic
one
standard
error
mean
sem
differ
growth
curv
assess
use
oneway
anova
tukey
multipl
comparison
test
differ
singlestep
growth
titr
popul
found
signific
p
data
analys
use
graphpad
prism
onlin
softwar
packag
version
http
wwwgraphpadcom
analysi
genom
replic
fidel
clone
popul
passag
presenc
ribavirin
develop
guanidin
resist
passag
presenc
ribavirin
previous
develop
guanidin
resist
assay
investig
replic
fidel
ribavirinresist
pol
variant
popul
sadeghipour
et
al
report
use
assay
compar
replic
fidel
phenotyp
parent
serial
passag
presenc
ribavirin
order
compar
frequenc
random
accumul
mutat
within
genom
parent
passag
presenc
ribavirin
seven
plaquepurifi
viru
popul
independ
deriv
stock
passag
rd
cell
presenc
ribavirin
resist
guanidin
rdpassag
viral
popul
determin
passag
level
thirteen
guanidin
sensit
seven
plaquepurifi
popul
growth
rd
cell
h
presenc
absenc
mm
guanidin
shown
fig
plaquepurifi
popul
grew
higher
titr
presenc
mm
guanidin
compar
plaquepurifi
popul
fig
data
suggest
clone
popul
higher
viral
rna
replic
fidel
phenotyp
growth
rd
cell
parent
viru
prevent
random
select
mutat
code
region
confer
guanidineresist
phenotyp
genom
mutat
frequenc
estim
nucleotid
sequenc
code
region
three
randomli
select
plaquepurifi
popul
cdv
respect
total
nucleotid
sequenc
cdv
mutat
frequenc
mutant
viru
repres
averag
number
chang
parent
fullgenom
consensu
sequenc
nucleotid
parent
acquir
averag
mutat
per
genom
nucleotid
rd
passag
contrast
acquir
averag
p
mutat
per
genom
respect
data
indic
high
replic
fidel
phenotyp
result
sixfold
fewer
mutat
introduc
genom
passag
presenc
ribavirin
compar
parent
viru
find
consist
previou
observ
sadeghipour
et
al
given
associ
increas
replic
fidel
polioviru
virul
anim
model
vignuzzi
et
al
vignuzzi
et
al
decid
investig
virul
high
replic
fidel
variant
mous
model
infect
chua
et
al
previous
show
major
molecular
determin
mous
adapt
virul
locat
capsid
protein
chua
et
al
furthermor
mouseadapt
phenotyp
gener
introduct
mutat
code
region
parent
infecti
cdna
clone
chua
et
al
order
studi
virul
high
replic
fidel
variant
mous
model
pol
code
region
cdna
fragment
carri
result
viral
titr
determin
assay
vero
cell
reed
muench
experi
perform
triplic
error
bar
indic
one
standard
error
mean
sem
c
guanidin
resist
ratio
calcul
viral
titr
presenc
guanidin
divid
titr
absenc
guanidin
base
final
titr
shown
fig
b
experi
perform
triplic
error
bar
indic
one
sem
mutat
clone
gener
mouseadapt
variant
respect
code
region
mouseadapt
cdv
amplifi
rtpcr
one
passag
rd
cell
sequenc
confirm
presenc
mous
adapt
marker
rescu
cdv
popul
data
shown
next
characteris
virul
mice
group
six
tabl
surviv
balbc
mice
infect
ip
inocul
tenfold
serial
dilut
dose
surviv
mockinfect
number
mice
surviv
group
six
mice
balbc
mice
infect
ip
tcid
tcid
tcid
tcid
tcid
respect
result
shown
tabl
infect
newborn
balbc
mice
tcid
tcid
tcid
tcid
respect
signific
differ
hd
valu
observ
parent
p
parent
p
contrast
differ
observ
hd
valu
parent
mean
surviv
time
mice
infect
tcid
parent
day
mean
surviv
time
mice
infect
tcid
day
mean
surviv
time
mice
infect
tcid
day
mean
surviv
time
mice
infect
tcid
day
mice
surviv
significantli
p
longer
mice
moreov
averag
surviv
mice
differ
mice
infect
p
mice
viru
first
detect
blood
tcid
ml
skelet
muscl
tcid
g
three
day
pi
fig
five
day
pi
present
blood
viral
titr
blood
determin
ml
viral
titr
skelet
muscl
homogen
determin
g
timepoint
repres
mean
tissu
titr
three
mice
error
bar
repres
one
standard
error
mean
sem
limit
detect
lod
viru
titrat
assay
dash
line
indic
lod
viru
titrat
arrow
indic
specimen
titr
lod
signific
differ
observ
skelet
muscl
growth
titr
parent
three
p
five
p
day
pi
signific
differ
also
observ
skelet
muscl
growth
titr
parent
three
p
five
p
day
pi
tcid
ml
skelet
muscl
tcid
g
high
skelet
muscl
tissu
titr
mice
consist
previou
observ
chua
et
al
mice
viru
first
detect
skelet
muscl
tcid
g
three
day
pi
five
day
pi
detect
blood
tcid
ml
skelet
muscl
tcid
g
signific
differ
growth
titr
observ
tissu
mice
fig
mice
viru
first
detect
three
day
pi
skelet
muscl
tcid
g
five
day
pi
detect
blood
tcid
ml
skelet
muscl
tcid
g
similarli
mice
viru
first
detect
three
day
pi
skelet
muscl
tcid
g
five
day
pi
detect
blood
tcid
ml
skelet
muscl
tcid
g
interest
note
viraemia
titr
mice
variabl
five
day
pi
compar
six
day
pi
statist
signific
differ
skelet
muscl
growth
titr
observ
three
p
five
p
day
pi
taken
togeth
find
indic
attenu
virul
phenotyp
mice
delay
onset
clinicallyappar
diseas
associ
lower
viral
titr
skelet
muscl
delay
onset
necrotis
skelet
muscl
myositi
see
histolog
studi
perform
order
determin
differ
viral
growth
mice
associ
differ
tissu
patholog
group
three
balbc
mice
inocul
ip
hd
histopatholog
chang
observ
skelet
muscl
tissu
pol
variantinfect
mice
shown
fig
histolog
abnorm
observ
skelet
muscl
ageequival
mockinfect
mice
fig
five
day
pi
sever
necrotis
myositi
observ
mice
fig
mice
fig
contrast
mild
focal
myositi
observ
mice
fig
mice
fig
five
day
pi
histolog
data
consist
find
tissu
distribut
analysi
fig
hightitr
skelet
muscl
infect
observ
mice
three
day
pi
wherea
high
titr
skelet
muscl
infect
mice
delay
five
day
pi
polioviru
strain
express
mutat
posit
pol
high
replic
fidel
phenotyp
attenu
polioviru
receptorexpress
transgen
mice
pfeiffer
kirkegaard
vignuzzi
et
al
vignuzzi
et
al
recent
extend
observ
demonstr
two
mutat
pol
gener
high
replic
fidel
phenotyp
restrict
genom
divers
sadeghipour
et
al
therefor
studi
interest
determin
pol
mutat
also
attenu
virul
prior
undertak
virul
studi
mice
construct
strain
incorpor
pol
mutat
plu
doubl
mutant
cdv
ribavirin
resist
sixfold
higher
replic
fidel
phenotyp
parent
viru
previous
shown
strain
incorpor
singl
pol
mutat
sadeghipour
et
al
furthermor
pol
mutat
alter
replic
capac
rd
cell
cultur
studi
shown
attenu
mice
clinicallyappar
diseas
significantli
skelet
muscl
tissu
collect
mice
day
pi
fix
buffer
formalin
overnight
dehydr
ethanol
embed
paraffin
tissu
specimen
sever
section
cut
microtom
mount
onto
glass
slide
vwr
labwar
stain
haematoxylin
eosin
tissu
section
examin
magnif
magnif
inset
bar
indic
length
delay
associ
lower
viral
titr
skelet
muscl
delay
onset
necrotis
skelet
muscl
myositi
contrast
attenu
mice
similar
virul
phenotyp
parent
viru
suggest
high
replic
fidel
may
sole
determin
virul
attenu
mouseadapt
howev
note
titr
blood
skelet
muscl
tissu
infect
mice
significantli
lower
mice
infect
parent
viru
especi
day
postinfect
suggest
mutat
may
impact
neg
viral
fit
vivo
without
lead
measur
decreas
virul
newborn
balbc
mice
two
altern
explan
inabl
identifi
virul
attenu
worth
note
firstli
inher
insensit
newborn
mous
model
infect
may
prevent
detect
attenu
due
mutat
secondli
possibl
ribavirin
mutagenesi
may
induc
virul
attenu
via
differenti
effect
quasispeci
divers
fit
popul
report
sanzramo
et
al
associ
ribavirin
resist
replic
fidel
viral
virul
phenotyp
complex
previous
note
high
replic
fidel
strain
polioviru
attenu
mice
pfeiffer
kirkegaard
vignuzzi
et
al
vignuzzi
et
al
furthermor
castro
et
al
identifi
conserv
lysin
residu
contribut
catalyt
effici
copi
fidel
nucleic
acid
polymeras
mutat
lysin
residu
arginin
polioviru
pol
gener
viru
popul
higher
replic
fidel
phenotyp
highli
attenu
mice
variant
week
et
al
similarli
mutat
alphaviru
chikungunya
rnadepend
rna
polymeras
increas
replic
fidel
decreas
genom
divers
also
impact
neg
viral
fit
vertebr
invertebr
host
coffey
vignuzzi
interestingli
mutat
coxsackieviru
pol
code
region
gener
low
replic
fidel
phenotyp
increas
genom
divers
also
attenu
virul
mice
et
al
furthermor
strain
sar
coronaviru
sarscov
engin
express
low
replic
fidel
inactiv
exonucleas
activ
stabli
attenu
mice
graham
et
al
sanzramo
et
al
report
ribavirin
mutagenis
footandmouth
diseas
viru
fmdv
popul
attenu
mice
even
though
larg
proport
clone
within
quasispeci
highli
virul
furthermor
mutat
associ
attenu
fmdv
popul
attenu
wild
type
viru
incorpor
infecti
clone
sanzramo
et
al
sanzramo
et
al
demonstr
mix
wildtyp
ribavirinmutagenis
fmdv
popul
attenu
mice
suggest
mutagenis
quasispeci
popul
exert
suppress
effect
virul
genom
length
sequenc
analysi
mix
viral
popul
virul
studi
ribavirinmutagenis
would
enabl
us
determin
mechan
also
contribut
attenu
phenotyp
mous
model
use
studi
chua
et
al
requir
prior
adapt
viru
thu
inabl
identifi
virul
attenu
strain
may
result
inher
insensit
model
studi
cynomolgu
macaqu
model
nagata
et
al
would
assist
investig
link
replic
fidel
virul
attenu
polioviru
receptorexpress
transgen
mice
provid
authent
model
investig
enteroviru
virul
ren
et
al
mous
adapt
two
human
receptor
scaveng
receptor
yamayoshi
et
al
pselectin
glycoprotein
nishimura
et
al
recent
identifi
howev
recent
studi
shown
pselectin
glycoprotein
transgen
mice
suscept
infect
liu
et
al
thu
develop
transgen
mice
express
scaveng
receptor
may
requir
provid
authent
mous
model
investig
virul
conclus
shown
mutat
confer
high
replic
fidel
upon
attenu
virul
newborn
balbc
mice
contrast
mutat
also
confer
high
replic
fidel
upon
attenu
although
suggest
high
replic
fidel
phenotyp
directli
respons
virul
attenu
model
studi
ribavirinmutagenis
popul
use
authent
anim
model
infect
requir
clarifi
issu
nevertheless
inform
emerg
molecular
process
involv
infect
virul
clearer
pictur
emerg
major
determin
virul
associ
replic
fidel
virul
final
inform
obtain
studi
potenti
use
develop
live
attenu
vaccin
protect
enceph
young
children
